Harvard Bioscience Inc (HBIO)
2.225
+0.06
(+3.01%)
USD |
NASDAQ |
Nov 22, 11:20
Harvard Bioscience Debt to Equity Ratio: 0.5796 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.5796 |
| June 30, 2024 | 0.5306 |
| March 31, 2024 | 0.5175 |
| December 31, 2023 | 0.5004 |
| September 30, 2023 | 0.5215 |
| June 30, 2023 | 0.5495 |
| March 31, 2023 | 0.5926 |
| December 31, 2022 | 0.6484 |
| September 30, 2022 | 0.6843 |
| June 30, 2022 | 0.6256 |
| March 31, 2022 | 0.6411 |
| December 31, 2021 | 0.5795 |
| September 30, 2021 | 0.588 |
| June 30, 2021 | 0.5482 |
| March 31, 2021 | 0.565 |
| December 31, 2020 | 0.6261 |
| September 30, 2020 | 0.5634 |
| June 30, 2020 | 0.5749 |
| March 31, 2020 | 0.6458 |
| December 31, 2019 | 0.6588 |
| September 30, 2019 | 0.7045 |
| June 30, 2019 | 0.6824 |
| March 31, 2019 | 0.7012 |
| December 31, 2018 | 0.7349 |
| September 30, 2018 | 0.754 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.7979 |
| March 31, 2018 | 0.7943 |
| December 31, 2017 | 0.1452 |
| September 30, 2017 | 0.1617 |
| June 30, 2017 | 0.1755 |
| March 31, 2017 | 0.1878 |
| December 31, 2016 | 0.1904 |
| September 30, 2016 | 0.1982 |
| June 30, 2016 | 0.2108 |
| March 31, 2016 | 0.2193 |
| December 31, 2015 | 0.2414 |
| September 30, 2015 | 0.2137 |
| June 30, 2015 | 0.2178 |
| March 31, 2015 | 0.242 |
| December 31, 2014 | 0.2247 |
| September 30, 2014 | 0.2397 |
| June 30, 2014 | 0.2265 |
| March 31, 2014 | 0.2443 |
| December 31, 2013 | 0.2619 |
| September 30, 2013 | 0.2179 |
| June 30, 2013 | 0.2301 |
| March 31, 2013 | 0.1437 |
| December 31, 2012 | 0.1243 |
| September 30, 2012 | 0.1524 |
| June 30, 2012 | 0.1643 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.5004
Minimum
Dec 2023
0.6843
Maximum
Sep 2022
0.587
Average
0.5796
Median
Debt to Equity Ratio Benchmarks
| Bruker Corp | 1.271 |
| Azenta Inc | 0.00 |
| Bionano Genomics Inc | 0.306 |
| Akoya Biosciences Inc | 5.568 |
| Singular Genomics Systems Inc | 0.0419 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 131.24M |
| Total Liabilities (Quarterly) | 65.92M |
| Shareholders Equity (Quarterly) | 65.32M |
| Current Ratio | 2.057 |
| Net Debt Paydown Yield | 0.61% |